Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Risk Indicators of Sarcoidosis Evolution-Unified Protocol

for
Sarcoidosis, Pulmonary
Location: Dallas TX, Baltimore MD
Sponsor: University of California, San Francisco

Sex: All

Age: 19+

Code: NCT05567133

Recruiting

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

for
Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 55+

Code: NCT05446584

Phase 2, Recruiting

Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery

for
Stage II Rectal Cancer, Organ Preservation,
Location: Dallas TX, Montreal, Quebec
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Sex: All

Age: 18 - 70+

Code: NCT03051464

Phase 2, Phase 3, Recruiting

The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

for
Aortoiliac Occlusive Disease, Peripheral Arterial Disease
Location: Dallas TX, New Orleans LA, Columbia MO, Denver CO,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18+

Code: NCT05811364

Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

for
Motor Function, Cognitive Function, Contrast Media
Location: Dallas TX, Peoria IL, Chicago IL, Madison WI,
Sponsor: Guerbet

Sex: All

Age: 18 - 64

Code: NCT04373564

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

for
Lower Respiratory Tract Infection
Location: Dallas TX, Milwaukee WI, Brooklyn NY, Stony Brook NY
Sponsor: MeMed Diagnostics Ltd.

Sex: All

Age: 18 - 70+

Code: NCT05762302

Recruiting

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

for
Urothelial Carcinoma, Urothelial Carcinoma Recurrent,
Location: Dallas TX, Houston TX, Columbia MO, Nashville TN,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT05874921

Recruiting

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

for
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS),
Location: Dallas TX, San Antonio TX, Houston TX, Little Rock AR,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 17

Code: NCT05267821

Phase 2, Phase 3, Recruiting

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

for
Low Risk Myelodysplastic Syndromes
Location: Dallas TX, Houston TX, St Louis MO, Columbus OH,
Sponsor: Rigel Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05308264

Phase 1, Phase 2, Recruiting

CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology

for
Urinary Incontinence, Urge
Location: Dallas TX, Saint Louis MO, Omaha NE, Columbus OH,
Sponsor: Uro Medical Corporation

Sex: All

Age: 18+

Code: NCT02577302

Recruiting

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

for
Congestive Heart Failure, Heart Failure, Systolic,
Location: Dallas TX, Saint Louis MO, San Diego CA,
Sponsor: Sardocor Corp.

Sex: All

Age: 18 - 70+

Code: NCT04703842

Phase 1, Phase 2, Recruiting

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

for
HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Dallas TX, San Antonio TX, Chicago IL, Chapel Hill NC,
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05029999

Phase 1, Recruiting

A Study of sEphB4-HSA in Kaposi Sarcoma

for
Kaposi Sarcoma
Location: Dallas TX, Sarasota FL, Beverly Hills CA
Sponsor: Vasgene Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT03993106

Phase 2, Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for
Prostate Cancer,
Location: Dallas TX, Houston TX, St Louis MO, Birmingham AL,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18 - 70+

Code: NCT05519449

Phase 1, Recruiting

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

for
Kidney Disease, End-Stage, End-stage Renal Disease,
Location: Dallas TX, Houston TX, Memphis TN, Chattanooga TN,
Sponsor: C. R. Bard

Sex: All

Age: 18+

Code: NCT04634916

Recruiting

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

for
Anesthesia, Surgery With General Anesthesia, Noncardiac Surgery,
Location: Dallas TX, Ann Arbor MI, Winston-Salem NC, Detroit MI,
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06802224

Recruiting

Preventing Cognitive Decline by Reducing BP Target Trial

for
Cognitive Decline, Blood Pressure, Hypertension
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 70+

Code: NCT05106036

Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Dallas TX, Houston TX, Germantown TN, Aurora CO,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

for
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma
Location: Dallas TX, Greenville SC, Huntersville NC,
Sponsor: FBD Biologics Limited

Sex: All

Age: 18+

Code: NCT05892718

Phase 1, Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Location: Dallas TX, Houston TX, Memphis TN, St Louis MO,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT03093116

Phase 1, Phase 2, Recruiting